News: SGO: Biomarkers accurate in ovarian cancer detection


The measurement of two biomarkers in women with ovarian masses appears to be accurate in disginguishing which patients are most likely to have cancer.

The measurement of two biomarkers in women with ovarian masses appears to be accurate in distinguishing which patients are most likely to have cancer, allowing those patients to be referred to gynecologic oncologists for further management, according to research findings presented at the 2008 Society of Gynecologic Oncologists' Annual Meeting on Women's Cancer in Tampa, FL.

Richard Moore, MD, of Brown University in Providence, RI, and colleagues measured the blood proteins HE4 and CA125II in nearly 500 women with ovarian masses participating in a clinical trial in order to determine the biomarkers' predictive value in detecting ovarian cancer.

The researchers found that a "high-risk" test result correctly predicted 95% of cases of epithelial ovarian cancer, while a "low-risk" result correctly predicted the absence of cancer in most patients, leading to a negative predictive value of 95%.

More details on this research can be found at http://

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:
Enhancing cervical cancer management with dual stain | Image Credit:
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit:
Understanding the impact of STIs on young adults | Image Credit:
CDC estimates of maternal mortality found overestimated | Image Credit:
Study unveils maternal mortality tracking trends | Image Credit:
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit:
Unveiling gender disparities in medicine | Image Credit:
Exploring the intersection of heart health and women's health | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.